Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era
The characteristics of HIV-associated ITP were documented prior to the HAART era, and the optimal treatment beyond HAART is unknown. We performed a review of patients with HIV-associated ITP and at least one platelet count <20 × 109/L since January 1996. Of 5290 patients in the BC Centre for Exce...
Saved in:
Main Authors: | Kimberley L. S. Ambler, Linda M. Vickars, Chantal S. Leger, Lynda M. Foltz, Julio S. G. Montaner, Marianne Harris, Viviane Dias Lima, Heather A. Leitch |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2012/910954 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Durable Red Blood Cell Transfusion Independence in a Patient with an MDS/MPN Overlap Syndrome Following Discontinuation of Iron Chelation Therapy
by: Harpreet Kochhar, et al.
Published: (2015-01-01) -
Echocardiographic Findings and Their Impact on Outcomes of Critically Ill Patients with AIDS in the Era of HAART
by: Abubakr A. Bajwa, et al.
Published: (2012-01-01) -
Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART
by: Rosmeri K. Lazzaretti, et al.
Published: (2013-01-01) -
Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome
by: Maha A. Badawi, et al.
Published: (2010-01-01) -
Hospitalization due to Adverse Drug Reactions and Drug Interactions before and after HAART
by: Michelle M Foisy, et al.
Published: (2000-01-01)